WVU Coach Huggins competes in Infiniti Coaches Charity Challenge to benefit cancer research

WVU Coach Huggins competes in Infiniti Coaches Charity Challenge to benefit cancer research

Vote to help Huggins win $100,000

MORGANTOWN, W.Va. – West Virginia University Men’s Basketball Coach Bob Huggins is looking to Mountaineer fans for their support to help him win $100,000 for the Norma Mae Huggins Cancer Research Endowment at the WVU Cancer Institute.

Huggins is one of 48 top college basketball coaches in the nation participating in the Infiniti Coaches’ Charity Challenge. The program, sponsored by luxury automobile manufacturer Infiniti, in partnership with the National Association of Basketball Coaches, the NCAA, and ESPN, benefits the coaches’ favorite charities.

Infiniti will donate at least $1,000 to each participating coach and will award $100,000 to the coach who receives the most fan votes over a 10-week period that ends on March 10.

Fans can vote three times a day for their favorite coach. Fans can vote at www.espn.com and can also vote across social media. For social media voting, fans can post images of themselves making a timeout gesture with the hashtags #Timeout2Vote and #CoachBobHuggins on Twitter and Instagram. All votes on social media will be collected and sent to ESPN for round totals. Following four rounds of voting, the coach who wins the grand prize will be announced on March 11 after voting ends.

This year’s Infiniti Challenge also includes a charity boost in which each charity has a chance to win additional money. During Round 1, Week 3 (from Jan. 15 to Jan. 22), any charity that is able to get 500 votes through social media will win an additional $500. During Round 2, Week 6 (from Feb. 5 to Feb. 12), any charity that is able to get 1,000 votes through social media will win an additional $1,000.

If Huggins wins the Infiniti Challenge, the prize money will go to the Norma Mae Huggins Cancer Research Endowment Fund he established at the Cancer Institute in memory of his mother who died in 2003 following a long battle with colon cancer. In keeping with Coach Huggins’ wishes, this fund supports clinical research, specifically providing access to cancer clinical trials at WVU Medicine affiliates for all West Virginians.

“Mountaineer fans are the greatest,” Huggins said. “But I want them to realize that this event isn’t a popularity contest. When they vote for me, they’ll be voting to find new and better treatments for cancer and bringing hope to those afflicted with the disease. Let’s show how supportive people in this great state are, and let’s win $100,000 for this great cause.”

For more information: Angela Jones-Knopf, Manager of Media Relations, 304-285-7259
  • WVU, partners announce regional hub to train entrepreneurs, commercialize healthcare technology

    WVU, partners announce regional hub to train entrepreneurs, commercialize healthcare technology

    Hoping to speed up the move from idea to application, West Virginia University and 23 other regional institutions have come together to create a “virtual hub” that will ultimately help speed the commercialization of groundbreaking university research. 

    Read More

  • Community-based research town hall

    WVCTSI and the WVU Mountaineer Health Initiative are co-sponsoring a town hall meeting to highlight research taking place across the state. “Conversation and Collaboration: WVU Community-Based Researchers and Outreach Staff Making a Difference,” offers attendees the chance to learn about the range of community engaged research and outreach across the state, meet colleagues engaged in similar work, identify common issues, and ascertain better ways to support each other in the field.

    Read More

  • Du Publishes Two Studies That Describe an Improved Approach to Bone Marrow Transplant

    Du Publishes Two Studies That Describe an Improved Approach to Bone Marrow Transplant

    WVU cancer researcher Wei Du, MD, PhD, teamed up with researchers from Cincinnati Children’s Hospital Medical Center to focus on improving outcomes and reducing side effects of traditional stem cell transplant. Their work was recently published in Leukemia, one of the top journals in hematology.

    Read More